Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000776812 | SCV000912467 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000776812 | SCV001185094 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002067344 | SCV002361282 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-05-09 | criteria provided, single submitter | clinical testing | |
Brotman Baty Institute, |
RCV001072821 | SCV001238269 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro |